Sort
23,748 grants matching “melanoma”
Project 1--Targeted therapies for pediatric low-grade astrocytoma (Eck/Wright/Haas)
$337,367Daphne A. Haas-Kogan · Brigham And Women'S Hospital · P50 · FY2019 · CA
Biological activity of ras oncogenes
$337,334University Of North Carolina Chapel Hill · R01 · FY2005 · CA
Targeted immunotherapy of breast cancer with central memory T cells
$337,324Stanley R Riddell · Fred Hutchinson Cancer Research Center · P50 · FY2011 · CA
Regulation of Melanocyte Differentiation by SWI/SNF Chromatin Remodeling Enzymes
$337,320Ivana L De La Serna · University Of Toledo Health Sci Campus · R01 · FY2012 · AR
Tumor-Specific Chemokine Modulation in Colorectal Cancer Versus Melanoma
$337,276Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · CA
MerTK and the Innate Immune Response to Melanoma
$337,268Henry Shelton Earp · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Nuclear Accumulation of D-type Cyclins and Oncogenesis
$337,255J. Alan Diehl · Case Western Reserve University · R01 · FY2022 · CA
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade
$337,216Harriet M Kluger · Yale University · P50 · FY2020 · CA
Southwest Oncology Group
$337,210Heinz Josef Lenz · University Of Southern California · U10 · FY2013 · CA
c-Myc Expression during Lymphomagenesis
$337,199M Alanna Ruddell · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Xenograft-like rejection of tumors in a-gal glycolipids
$337,188Uri Galili · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · CA
Xenograft-like rejection of tumors in a-gal glycolipids
$337,188Uri Galili · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · CA
Xenograft-like rejection of tumors in a-gal glycolipids
$337,188Uri Galili · Univ Of Massachusetts Med Sch Worcester · R01 · FY2008 · CA
IFN ALPHA-INDUCED DEPRESSION
$337,175Emory University · R01 · FY2000 · MH
Adoptive T Cell Therapy of Melanoma Targeting NY-ESO-1
$337,154Cassian Yee · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
CD91 and cancer immunosurveillance
$337,148Robert J Binder · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Regulation of Melanocyte Differentiation by SWI/SNF Chromatin Remodeling Enzymes
$337,107Ivana L De La Serna · University Of Toledo Health Sci Campus · R01 · FY2011 · AR
In Vivo Selection of Ligands for Targeted Therapy
$337,088University Of Vermont &St Agric College · R21 · FY2003 · CA
In Vivo Selection of Ligands for Targeted Therapy
$337,088University Of Vermont &St Agric College · R21 · FY2002 · CA
Tumor Assessment Core
$336,975Stan Krajewski · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · CA
Novel TYRO3 inhibitors for treatment of cancer
$336,957Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
TOTAL SYNTHESES OF INDOLE ALKALOIDS
$336,925University Of Vermont &St Agric College · R01 · FY2000 · CA
Molecular Signaling within a Regenerative Neurovascular Niche after Stroke
$336,875Stanley Thomas Carmichael · University Of California Los Angeles · R01 · FY2015 · NS
Molecular Signaling within a Regenerative Neurovascular Niche after Stroke
$336,875Stanley Thomas Carmichael · University Of California Los Angeles · R01 · FY2013 · NS
Molecular Signaling within a Regenerative Neurovascular Niche after Stroke
$336,875Stanley Thomas Carmichael · University Of California Los Angeles · R01 · FY2016 · NS